Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Veranova, ChemExpress invest in ADC facilities; Cohance to set up oligonucleotide facility in India

    Data Compilation
    #PharmaFlow

    Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

    Stock Recap
    #PipelineProspector

    Menu

    Eprosartan Mesylate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 222Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    10/10/2025 Hetero Drugs
    India
    		 M/s Hetero Drugs Limited WC-0040 Eprosartan Mesylate IH/USP 2025-09-19 2028-07-03 Unit-l, Sy. No. 213, 214 & 255, Bonthapally (Village),Gummadidala (Mandal), Sangareddy (Dist.),Telangana, India
    09/10/2025 Unichem Laboratories Limited
    India
    		 M/s Unichem Laboratories Limited WC-0062 Eprosartan Mesylate IH 2025-09-19 2028-07-27 Plot No. 197, Sector -I, Pithampur -454775, District -Dhar (MP), India.